Key result
Early rhythm control within 6 months linked to ~15% fewer CV events in AF.
Why the study?
To investigate the associations between sex and the relative effect of rhythm control over rate control in patients with atrial fibrillation.
Does early rhythm control improve cardiovascular outcomes compared to rate control in men and women with atrial fibrillation?
Cohort (n=28,049)
Does early rhythm control improve cardiovascular outcomes compared to rate control in men and women with atrial fibrillation?
Early rhythm control within 6 months of atrial fibrillation diagnosis improves cardiovascular outcomes in both sexes, but delayed initiation beyond 6 months loses efficacy in women while remaining beneficial in men.
Answers are grounded in this paper and cite their sources.
Supports early rhythm control within 6 months of AF diagnosis in both sexes; leaves open sex-specific timing effects pending randomized confirmation.
Background: This study aimed to investigate the associations between sex and the relative effect of rhythm control over rate control in patients with atrial fibrillation. Methods: We used the National Health Insurance Service database to select patients treated for atrial fibrillation within one year after diagnosis. The primary composite outcome comprised cardiovascular death, ischemic stroke, heart failure hospitalization, or acute myocardial infarction. Results: During the mean follow-up (4.9 ± 3.2 years), the benefit of rhythm control over rate control on the primary composite outcome became statistically insignificant after 3 months from atrial fibrillation diagnosis in women while remained steadily until 12 months in men. The risk of primary composite outcome for rhythm control was lower than that for rate control in both sexes if it was initiated within 6 months (men: HR = 0.86, 95%CI = 0.79–0.94; women: HR = 0.85, 95%CI = 0.78–0.93; P for interaction = 0.844). However, there was significant interaction between sex and the relative effect of rhythm control if it was initiated after 6 months (men: HR = 0.72, 95%CI = 0.52–0.99; women: HR = 1.32, 95%CI = 0.92–1.88; P for interaction = 0.018). Conclusion: Rhythm control resulted in lower risk of primary composite outcome than rate control in both sexes; however, the treatment initiation at an earlier stage might be considered in women.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2022) conducted a cohort in Atrial fibrillation (n=28,049). Early rhythm control vs. Rate control was evaluated on Composite of cardiovascular death, ischemic stroke, heart failure hospitalization, or acute myocardial infarction (HR 0.85, 95% CI 0.78-0.93, p=<0.001). Early rhythm control reduced cardiovascular events in men and women when initiated within 6 months of atrial fibrillation diagnosis, but the benefit was lost in women if delayed.
Synapse has enriched 10 related papers. Consider them for comparative context: